BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 36575580)

  • 1. Patient perspectives on repeated contrast-enhanced mammography and magnetic resonance during neoadjuvant chemotherapy of breast cancer.
    Pires-Gonçalves L; Henriques Abreu M; Ferrão A; Guimarães Dos Santos A; Aguiar AT; Gouvêa M; Henrique R
    Acta Radiol; 2023 May; 64(5):1816-1822. PubMed ID: 36575580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrast-enhanced spectral mammography in neoadjuvant chemotherapy monitoring: a comparison with breast magnetic resonance imaging.
    Iotti V; Ravaioli S; Vacondio R; Coriani C; Caffarri S; Sghedoni R; Nitrosi A; Ragazzi M; Gasparini E; Masini C; Bisagni G; Falco G; Ferrari G; Braglia L; Del Prato A; Malavolti I; Ginocchi V; Pattacini P
    Breast Cancer Res; 2017 Sep; 19(1):106. PubMed ID: 28893303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast-Enhanced Mammography (CEM) for Detecting Residual Disease after Neoadjuvant Chemotherapy: A Comparison with Breast Magnetic Resonance Imaging (MRI).
    Barra FR; Sobrinho AB; Barra RR; Magalhães MT; Aguiar LR; de Albuquerque GFL; Costa RP; Farage L; Pratesi R
    Biomed Res Int; 2018; 2018():8531916. PubMed ID: 30533440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrast-Enhanced Mammography Versus MRI in the Evaluation of Neoadjuvant Therapy Response in Patients With Breast Cancer: A Prospective Study.
    Bernardi D; Vatteroni G; Acquaviva A; Valentini M; Sabatino V; Bolengo I; Pellegrini M; Fantò C; Trimboli RM
    AJR Am J Roentgenol; 2022 Dec; 219(6):884-894. PubMed ID: 35731101
    [No Abstract]   [Full Text] [Related]  

  • 5. Contrast-enhanced mammography in the assessment of residual disease after neoadjuvant treatment.
    Hogan MP; Horvat JV; Ross DS; Sevilimedu V; Jochelson MS; Kirstein LJ; Goldfarb SB; Comstock CE; Sung JS
    Breast Cancer Res Treat; 2023 Apr; 198(2):349-359. PubMed ID: 36754936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic Performance of MRI, Molecular Breast Imaging, and Contrast-enhanced Mammography in Women with Newly Diagnosed Breast Cancer.
    Sumkin JH; Berg WA; Carter GJ; Bandos AI; Chough DM; Ganott MA; Hakim CM; Kelly AE; Zuley ML; Houshmand G; Anello MI; Gur D
    Radiology; 2019 Dec; 293(3):531-540. PubMed ID: 31660801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrast-enhanced digital breast tomosythesis and breast MRI to monitor response to neoadjuvant chemotherapy: patient tolerance and preference.
    Savaridas SL; Whelehan P; Warwick VR; Vinnicombe SJ; Evans AJ
    Br J Radiol; 2022 Jun; 95(1134):20210779. PubMed ID: 35143334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Head-to-head comparison of contrast-enhanced mammography and contrast-enhanced MRI for assessing pathological complete response to neoadjuvant therapy in patients with breast cancer: a meta-analysis.
    Kaiyin M; Lingling T; Leilei T; Wenjia L; Bin J
    Breast Cancer Res Treat; 2023 Nov; 202(1):1-9. PubMed ID: 37615793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accuracy of Contrast-Enhanced Ultrasound Compared With Magnetic Resonance Imaging in Assessing the Tumor Response After Neoadjuvant Chemotherapy for Breast Cancer.
    Lee SC; Grant E; Sheth P; Garcia AA; Desai B; Ji L; Groshen S; Hwang D; Yamashita M; Hovanessian-Larsen L
    J Ultrasound Med; 2017 May; 36(5):901-911. PubMed ID: 28150325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast-enhanced mammography in breast cancer screening.
    Coffey K; Jochelson MS
    Eur J Radiol; 2022 Nov; 156():110513. PubMed ID: 36108478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient preferences regarding use of contrast-enhanced imaging for breast cancer screening.
    Son D; Phillips J; Mehta TS; Mehta R; Brook A; Dialani VM
    Acad Radiol; 2022 Jan; 29 Suppl 1():S229-S238. PubMed ID: 33846061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrast-enhanced Mammography: Current Applications and Future Directions.
    Ghaderi KF; Phillips J; Perry H; Lotfi P; Mehta TS
    Radiographics; 2019; 39(7):1907-1920. PubMed ID: 31697627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative evaluation of breast cancer: Contrast-enhanced mammography versus contrast-enhanced magnetic resonance imaging: A systematic review and meta-analysis.
    Shahraki Z; Ghaffari M; Nakhaie Moghadam M; Parooie F; Salarzaei M
    Breast Dis; 2022; 41(1):303-315. PubMed ID: 35754256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic contrast-enhanced mammography and breast MRI in the diagnosis of breast cancer and detection of tumor size.
    Tekinhatun M; Sabir N; Erdem E; Yilmaz S; Ufuk F
    Turk J Med Sci; 2024; 54(1):249-261. PubMed ID: 38812642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analytic Hierarchy Process Analysis of Patient Preferences for Contrast-Enhanced Mammography Versus MRI as Supplemental Screening Options for Breast Cancer.
    Berg WA; Bandos AI; Sava MG
    J Am Coll Radiol; 2023 Aug; 20(8):758-768. PubMed ID: 37394083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrast-enhanced Mammography versus Contrast-enhanced Breast MRI: A Systematic Review and Meta-Analysis.
    Pötsch N; Vatteroni G; Clauser P; Helbich TH; Baltzer PAT
    Radiology; 2022 Oct; 305(1):94-103. PubMed ID: 36154284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The PROCEM study protocol: Added value of preoperative contrast-enhanced mammography in staging of malignant breast lesions - a prospective randomized multicenter study.
    Åhsberg K; Gardfjell A; Nimeus E; Ryden L; Zackrisson S
    BMC Cancer; 2021 Oct; 21(1):1115. PubMed ID: 34663236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is contrast-enhanced mammography (CEM) an alternative to MRI in assessing the response to primary systemic therapy of breast cancer?
    Sunen I; Isabel Garcia Barrado A; Cruz Ciria S; Garcia Maroto J; Gros Bañeres B; Garcia Mur C
    Eur J Radiol; 2024 Jan; 170():111270. PubMed ID: 38141263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast-Enhanced Mammography (CEM) compared to Breast Magnetic Resonance (MRI) in the evaluation of breast lobular neoplasia.
    Nicosia L; Rotili A; Pesapane F; Bozzini AC; Battaglia O; Pellegrino G; Fusco N; Porta FM; Frassoni S; Bagnardi V; Corso G; Sangalli C; Cassano E
    Breast Cancer Res Treat; 2024 Jan; 203(1):135-143. PubMed ID: 37787819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of contrast-enhanced mammography for diagnosis of breast cancer].
    Fischer U; Diekmann F; Helbich T; Preibsch H; Püsken M; Wenkel E; Wienbeck S; Fallenberg EM
    Radiologie (Heidelb); 2023 Dec; 63(12):916-924. PubMed ID: 37889284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.